Cizzle Biotechnology (UK) Today
| CIZ Stock | 1.65 0.10 6.45% |
PerformanceInsignificant
| Odds Of DistressLow
|
Cizzle Biotechnology is trading at 1.65 as of the 26th of March 2025, a 6.45 percent increase since the beginning of the trading day. The stock's lowest day price was 1.6. Cizzle Biotechnology has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Cizzle Biotechnology is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 396.39 M outstanding shares. More on Cizzle Biotechnology Holdings
Moving against Cizzle Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cizzle Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cizzle Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cizzle Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | Allan Syms | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Computers, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) | ||||
Cizzle Biotechnology's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cizzle Biotechnology's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCizzle Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cizzle Biotechnology's financial leverage. It provides some insight into what part of Cizzle Biotechnology's total assets is financed by creditors.
| |||||
Cizzle Biotechnology Holdings (CIZ) is traded on London Exchange in UK and employs 4 people. Cizzle Biotechnology is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cizzle Biotechnology's market, we take the total number of its shares issued and multiply it by Cizzle Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cizzle Biotechnology operates under Biotechnology sector and is part of Health Care industry. The entity has 396.39 M outstanding shares.
Cizzle Biotechnology generates negative cash flow from operations
Check Cizzle Biotechnology Probability Of Bankruptcy
Ownership AllocationCizzle Biotechnology holds a total of 396.39 Million outstanding shares. Cizzle Biotechnology Holdings retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cizzle Ownership Details
Cizzle Biotechnology Risk Profiles
Although Cizzle Biotechnology's alpha and beta are two of the key measurements used to evaluate Cizzle Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.47 | |||
| Semi Deviation | 4.31 | |||
| Standard Deviation | 6.0 | |||
| Variance | 36.05 |
Cizzle Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cizzle Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Cizzle Stock
Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.